Japan's Chuikyo (Central Social Insurance Medical Council) has approved the Ministry of Health, Labor and Welfare's plan to strongly urge medical facilities and pharmacies to comply with the obligation to make efforts to use generic drugs. This was stipulated in the medical treatment rules for health insurance physicians and pharmacists under the ministry's ordinance upon the changes of the 2008 medical fee revision, through local health authorities because some physicians and pharmacists are declining to use generic drugs, according to MHLW survey data (Marketletter May 4).
In addition, the MHLW plans to call for insurers to provide the insured with "a wish card for generic drugs," pamphlets/leaflets on generic drugs, and for medical facilities to share the lists of copy products which are stocked by pharmacies in their community. The MHLW will also publish data on its examinations/tests for the quality of copy versions if some concerns about the these are raised, deploy a specific panel for promoting the use of generics, consisting of civil servants, drugmakers, physicians, pharmacists and consumers in each prefecture (already established in 29 regions), and to hold seminars on the quality of copy medicines.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze